{rfName}
Ge

Indexed in

License and use

Icono OpenAccess

Altmetrics

Analysis of institutional authors

Garcia-Mulero SAuthorSanz-Pamplona RAuthor

Share

Publications
>
Article

Genetic and immune changes associated with disease progression under the pressure of oncolytic therapy in a neuroblastoma outlier patient

Publicated to:Cancers. 12 (5): E1104- - 2020-05-01 12(5), DOI: 10.3390/cancers12051104

Authors: Franco-Luzón, L; García-Mulero, S; Sanz-Pamplona, R; Melen, G; Ruano, D; Lassaletta, A; Madero, L; González-Murillo, A; Ramírez, M

Affiliations

Bellvitge Biomed Res Inst IDIBELL, Catalan Inst Oncol ICO, Unit Biomarkers & Susceptibil, ODAP,Oncobell Program, Barcelona 08908, Spain - Author
Children Oncohematol Fdn, Madrid 28079, Spain - Author
Children Oncohematology Foundation - Author
CIBERESP, Barcelona 08908, Spain - Author
Health Research Institute Princesa - Author
Hosp Infantil Univ Nino Jesus, Oncohematol Unit, Madrid 28009, Spain - Author
Hospital Infantil Universitario Niño Jesús de Madrid - Author
Institut d'investigació biomèdica de bellvitge - Author
La Princesa Inst Hlth Res, Madrid 28006, Spain - Author
Nino Jesus Children Hosp, Biomed Res Fdn, Madrid 28009, Spain - Author
Niño Jesús Children's Hospital - Author
Univ Barcelona, Fac Med & Hlth Sci, Dept Clin Sci, Barcelona 08036, Spain - Author
Universitat de Barcelona - Author
See more

Abstract

Keywords

bioinformatic analysisimmune landscapekeywords: neuroblastomat lymphocytes (tils)ActivationB-lymphocytesBioinformatic analysisCancerCell-receptor repertoireChemotherapyExpressionIcovir-5Immune landscapeImmunotherapyKeywords: neuroblastomaNeural-networksNeuroblastomaOncolytic virotherapyT lymphocytes (tils)Virotherapy

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Cancers due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2020, it was in position 51/242, thus managing to position itself as a Q1 (Primer Cuartil), in the category Oncology.

From a relative perspective, and based on the normalized impact indicator calculated from the Field Citation Ratio (FCR) of the Dimensions source, it yields a value of: 3.15, which indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: Dimensions Jun 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-06-23, the following number of citations:

  • WoS: 14
  • Scopus: 17
  • Europe PMC: 8
  • OpenCitations: 13

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-06-23:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 29.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 29 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 13.85.
  • The number of mentions on the social network X (formerly Twitter): 19 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.